TMC Life Sciences (0101.KU) - Malaysia
(3rd) quarter ended Mar 31:
Figures Are In Ringgit (MYR).
2026 2025
Revenue 89,701,000 89,872,000
PreTax Profit 2,749,000 52,000
Net Profit 1,758,000 -806,000
Earnings Per Share 0.10 Sen -0.05 Sen
Dividend 0.00 Sen 0.00 Sen
9 months ended Mar 31:
Revenue 293,675,000 252,265,000
PreTax Profit 18,653,000 4,018,000
Net Profit 12,732,000 1,183,000
Earnings Per Share 0.73 Sen 0.07 Sen
Dividend 0.00 Sen 0.00 Sen
(END) Dow Jones Newswires
May 20, 2026 05:46 ET (09:46 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.